Zymeworks Announces Participation in Upcoming Investor Conferences and Date of Third Quarter 2026 Financial Results
Globe Newswire•15/10/2026•06:00 ET
0
Key Highlights
- ➤Q3 2026 financial results scheduled after market close November 9, 2026
- ➤No conference call or webcast planned for third-quarter results
- ➤Management to attend four healthcare investor conferences November 10-17
- ➤Fireside chat webcasts and replays available for select investor events
VANCOUVER, British Columbia, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced that management will report its third quarter 2026 financial results after market close on November 9, 2026.
Consistent with its current practice, Zymeworks does not plan to host a conference call or webcast for its third quarter 2026 financial results. Management looks forward to engaging with the investment community at upcoming events.
Get started
Create a free account to read the full story.